Companies: Amersham

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Companies
Company details

Amersham

A world leader in the provision of products and services for in vivo medical diagnosis and in life sciences

Summary

Headquarted in Buckinghamshire, UK, Amersham is a company that specialises in medical diagnostics and technologies and products that aid the life sciences.

R&D

To view this information, you must subscribe to PL Intelligence.

Partnerships

To view this information, you must subscribe to PL Intelligence.

Deals

To view this information, you must subscribe to PL Intelligence.

Contact details

To view this information, you must subscribe to PL Intelligence.

Head office

Amersham
Amersham Place
Little Chalfont
Buckinghamshire
HP7 9NA
United Kingdom

Visit website

Related companies

Decision Resources Inc.

Palau Pharma

APR Applied Pharma Research S.A.

BiotechEast Co., Ltd. (Technology Partner)

Amarin Technologies S.A.

Related categories

Industry sector: Biotechnology / Diagnostic test systems; Biotechnology / Human diagnostics; Biotechnology / Other; Diagnostic / CAT; Diagnostic / Imaging; Diagnostic / MRI; Diagnostic / Nuclear medicine; Diagnostic / Ultrasound; Diagnostic / Supplies; Diagnostic / Test systems / In-vivo systems; Diagnostic / Test systems / Other; Diagnostic / Supplies / Reagents
Therapeutic target: Cardiovascular; Cardiovascular / Cardiovascular disorder (other); Cardiovascular / Acute coronary syndromes / Angina; Central Nervous System; Central Nervous System / Neurodegenerative disorders; Central Nervous System / Pain / Pain, inflammatory; Central Nervous System / Psychiatric / Schizophrenia; Central Nervous System / Pain / Pain management general; Genito-urinary; Genito-urinary / Gender related medicine female / Endometriosis; Musculoskeletal; Musculoskeletal / Muscular / Inflammation; Musculoskeletal / Skeletal / Arthritis (non-specific); Musculoskeletal / Skeletal / Rheumatic disorders (other); Oncology; Oncology / Prostate cancer; Oncology / Cancer (other); Oncology / Bone cancer; Oncology / Treatments / Chemotherapy; Oncology / Treatments / Radiotherapy; Respiratory

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us